October

Fisher Clinical Services, Inc. (PDF) (October 4, 2023)

Final Order: Adjustment to the Aggregate Production Quota for Methylphenidate (for Sale) for 2023 (PDF) (October 3, 2023)

September

DEA Increases Production Quota to Manufacture Medication to Treat Attention Deficit Disorder (September 29, 2023)

Eli-Elsohly Laboratories (PDF) (September 29, 2023)

Maridose LLC (PDF) (September 29, 2023)

Curia Wisconsin, Inc. (PDF) (September 29, 2023)

VHG Labs dba LGC Standards (PDF) (September 29, 2023)

Restek Corporation (PDF) (September 29, 2023)

Restek Corporation (PDF) (September 29, 2023)

Cambridge Isotope Laboratories, Inc. (PDF) (September 29, 2023)

Proposed Rule: Placement of Ethylphenidate in Schedule I (PDF) (September 22, 2023)

60-Day Notice: Report of Theft or Loss of Controlled Substance and Report of Loss or Disappearance of Listed Chemicals (PDF) (September 20, 2023)

AndersonBrecon, Inc. DBA PCI Pharma Services (PDF) (September 15, 2023)

AMPAC Fine Chemicals Virginia LLC (PDF) (September 15, 2023)

Olon Ricerca Bioscience, LLC (PDF) (September 15, 2023)

Curia New York, Inc. (PDF) (September 15, 2023)

Experic LLC (PDF) (September 15, 2023)

Veterans Pharmaceuticals, Inc. (PDF) (September 15, 2023)

Cambrex High Point, Inc. (PDF) (September 15, 2023)

Benuvia Operations, LLC (PDF) (September 15, 2023)

PCI Synthesis (PDF) (September 15, 2023)

Green Wave Analytical Decision and Order (PDF) (September 14, 2023)

Rachel Pittala, APRN; Decision and Order (PDF) (September 14, 2023)

60-Day Notice: Controlled Substances Import/Export Declaration (PDF) (September 11, 2023)

60-Day Notice: Import/Export Declaration for List I and List II Chemicals (PDF) (September 11, 2023)

60-Day Notice: Application for Permit To Import Controlled Substances for Domestic and/or Scientific Purposes (PDF) (September 11, 2023)

60-Day Notice: Report of Loss or Disappearance of Listed Chemicals and Regulated Transactions in Tableting/Encapsulating Machines (PDF) (September 11, 2023)

60-Day Notice: Application for Permit To Export Controlled Substances, Application for Permit To Export Controlled Substances for Subsequent Reexport (PDF) (September 11, 2023)

August

TELEMEDICINE LISTENING SESSION (August 22, 2023)

Catalent CTS, LLC (PDF) (September 1, 2023)

Fisher Clinical Services, Inc. (PDF) (September 1, 2023)

Curia Wisconsin, Inc. (PDF) (September 1, 2023)

Final Rule: Management of Quotas for Controlled Substances and List I Chemicals (PDF) (August 31, 2023)

DEA Hosts Public Listening Sessions on Telemedicine Regulations (August 7, 2023)

Pisgah Laboratories Inc. (PDF) (August 22, 2023)

Irvine Labs Inc. (PDF) (August 22, 2023)

Cambrex Charles City (PDF) (August 22, 2023)

Final Order: Placement of Metonitazene in Schedule I (PDF) (August 18, 2023)

Ndubuisi J. Okafor, M.D.; Decision and Order (PDF) (August 18, 2023)

William Tuong, M.D.; Decision and Order (PDF) (August 18, 2023)

FDA and DEA Joint Letter on Shortages in Prescription Stimulants (PDF) (August 1, 2023)

Curium US LLC (PDF) (August 17, 2023)

Vici Health Sciences, LLC (PDF) (August 17, 2023)

David H. Marcowitz, D.O.; Decision and Order (PDF) (August 14, 2023)

Weise Prescription Shop Inc.; Decision and Order (PDF) (August 14, 2023)

Olga Wildfeuer, M.D.; Decision and Order (PDF) (August 14, 2023)

Stephen K. Jones, M.D.; Decision and Order (PDF) (August 14, 2023)

Debora Ryder, N.P.; Decision and Order (PDF) (August 14, 2023)

Yogeshwar Gill, M.D.; Decision and Order (PDF) (August 14, 2023)

Continuus Pharmaceuticals (PDF) (August 10, 2023)

Caligor Coghlan Pharma Services (PDF) (August 10, 2023)

Chattem Chemicals (PDF) (August 10, 2023)

Chemtos, LLC (PDF) (August 9, 2023)

Cambrex Charles City (PDF) (August 9, 2023)

Cambrex High Point, Inc. (PDF) (August 9, 2023)

Catalent Pharma Solutions, LLC (PDF) (August 9, 2023)

Galephar Pharmaceutical Research, Inc. (PDF) (August 9, 2023)

Cerilliant Corporation (PDF) (August 9, 2023)

ANI Pharmaceuticals Inc. (PDF) (August 9, 2023)

Final Rule: Dispensing of Narcotic Drugs To Relieve Acute Withdrawal Symptoms of Opioid Use Disorder (PDF) (August 8, 2023)

Notice: Practice of Telemedicine: Listening Sessions (PDF) (August 7, 2023)

Final Rule: Implementation of the Designer Anabolic Steroid Control Act of 2014 (PDF) (August 1, 2023)

July

Final Rule: Transfer of Electronic Prescriptions for Schedules II-V Controlled Substances Between Pharmacies for Initial Filling (PDF) (July 27, 2023)

Temporary Amendment: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (PDF) (July 26, 2023)

Veranova, L.P.; Correction (PDF) (July 24, 2023)

Final Rule: Partial Filling of Prescriptions for Schedule II Controlled Substances (PDF) (July 21, 2023)

Placement of Brorphine in Schedule I; Correction (PDF) (July 19, 2023)

Biopharmaceutical Research Company (PDF) (July 18, 2023)

Restek Corporation (PDF) (July 12, 2023)

Aurobindo Pharma USA, Inc. (PDF) (July 12, 2023)

June

60-Day Notice: U.S. Official Order Forms for Schedules I and II Controlled Substances DEA Form 222 (PDF) (June 30, 2023)

Irvine Labs, Inc. (PDF) (June 29, 2023)

American Radiolabeled Chem (PDF) (June 26, 2023)

Arista Biologicals (PDF) (June 26, 2023)

Olon Ricerca Bioscience LLC (PDF) (June 26, 2023)

Final Rule: Reporting Theft or Significant Loss of Controlled Substances (PDF) (Thursday, June 22, 2023)

Alcami Carolinas Corporation (PDF) (June 20, 2023)

Notice of Proposed Updates: Special Surveillance List of Chemicals, Products, Materials and Equipment Used in the Manufacture of Controlled Substances and Listed Chemicals (PDF) (June 16, 2023)

Veranova, L.P. (PDF) (June 12, 2023)

Wedgewood Village Pharmacy, LLC (PDF) (June 12, 2023)

AMPAC Fine Chemicals, LLC (PDF) (June 7, 2023)

Catalent Greenville, Inc. (PDF) (June 7, 2023)

Arizona Department of Corrections (PDF) (June 7, 2023)

Biopharmaceutical Research Company (PDF) (June 7, 2023)

Bright Green Corporation (PDF) (June 7, 2023)

Usona Institute, Inc. (PDF) (June 7, 2023)

Veranova, L.P. (PDF) (June 2, 2023)

May

Morris & Dickson Co., LLC; Decision and Order (PDF) (May 30, 2023)

Morris & Dickson Co., LLC; Order (PDF) (May 30, 2023)

30-Day Notice: Application for Registration and Application for Registration Renewal; DEA Forms 224, 224A (PDF) (May 26, 2023)

Keith Ly, M.D.; Decision and Order (PDF) (May 25, 2023)

Gary Gray d/b/a Complex; Decision and Order (PDF) (May 25, 2023)

Usona Institute (PDF) (May 25, 2023)

AndersonBrecon Inc. (PDF) (May 25, 2023)

VA Cooperative Studies Program (PDF) (May 25, 2023)

Veranova, L.P. (PDF) (May 25, 2023)

Benuvia Operations LLC (PDF) (May 25, 2023)

Irvine Labs, Inc. (PDF) (May 25, 2023)

Patheon API Manufacturing, Inc. (PDF) (May 25, 2023)

Galephar Pharmaceuticals Research, Inc. (PDF) (May 25, 2023)

Royal Emerald Pharmaceuticals (PDF) (May 25, 2023)

Royal Emerald Pharmaceuticals (PDF) (May 25, 2023)

Promega Corporation (PDF) (May 25, 2023)

Unither Manufacturing LLC (PDF) (May 25, 2023)

United States Pharmacopeial Convention (PDF) (May 25, 2023)

Almac Clinical Services Incorp. (ACSI) (PDF) (May 25, 2023)

Exempt Chemical Preparations Under the Controlled Substances Act (PDF) (May 22, 2023)

Asim A. Hameedi, M.D.; Stay of Decision and Transmittal Order (PDF) (May 12, 2023)

Temporary Rule: Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (PDF) (May 10, 2023)

IQVIA Report on Stimulant Trends from 2012 - 2021 (PDF) (October 31, 2022)